A couple of weeks ago, we interviewed F1000Research author Joel Huberman about his experiences with our journal. He published an article about the control of timing of telomere replication in fission yeast. In this study, he set out to investigate whether fission yeast telomere replication is similar to that of budding yeast, where replication timing…
We at F1000Research have a strong belief in transparency: transparency in peer review; transparency in research that is published, through the release and publication of all the underlying data; and transparency in publication, through acceptance of both positive and the ’unexciting’ negative and null findings to reduce the current positive publication bias. Most scientists we…
[NB: this campaign has been extended until the end of September. Read more.] Negative, and proud of it! It can be very difficult to get papers presenting negative or null results published. Many important results from scientific experiments are never published in the traditional peer reviewed literature, but negative and null results present a particular…
(This is the final installment of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication, Keith Flaherty on publishing negative results , Steven Hyman on sharing datasets, Sue Griffin on transparent peer review,…
(This is part 4 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication, Keith Flaherty on publishing negative results , Steven Hyman on sharing datasets, Sue Griffin on transparent peer review) Gary…
(This is part 4 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication, Keith Flaherty on publishing negative results , Steven Hyman on sharing datasets ) Sue Griffin is is Dillard Professor…
(This is part 3 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication, Keith Flaherty on publishing negative results.) Steven Hyman is Distinguished Service Professor of Stem Cell and Regenerative Biology and…
Advice to the European Medicines Agency (EMA) on data release from clinical trials, published last week, should ultimately help to improve healthcare but reveals widely divided opinion on exactly how data sharing should happen. The advice documents cover different aspects of clinical data sharing and reuse. Five advisory groups discussed: protecting patient confidentiality, data formats,…
(This is part 2 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication.) Keith Flaherty is Director of Developmental Therapeutics at the Massachusetts Cancer Center. In his talk he addressed the benefits…
We recently hosted “Challenging the Science Publishing Status Quo”, an evening of talks and discussion with several distinguished speakers. Each guest speaker focused on one particular aspect of publishing and peer review. We’ve recorded all the talks, and will be posting them one by one, starting today, and continuing throughout next week. The guest speaker…
